Scott Boitano

Parmedics, Inc.

NIH Rank #7843
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$1.6M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#7,843
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.6M across 2 grants · National rank #7843.

Top grants by award amount

Scott Boitano's NIH grant portfolio, ranked by award amount.

  • 2R44HL160424-02A1R44
    Pharmacokinetic and Efficacy Studies of the Aerosolized PAR2 Antagonist, C781, for the Treatment of Asthma
    $878.4K
    award amount
  • 1R01AI174540-01A1R01
    A role for pharmaceutical control of protease-activated receptor-2 for the treatment of asthma
    $716.7K
    award amount

Affiliations

Institutions that have administered grants for Scott Boitano.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Parmedics, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #7843
  5. 2024
    Multi-Institutional Research
    Awards at 2 institutions

Related investigators

Other NIH-funded PIs frequently associated with Scott Boitano.